Stocktoria
Merck KGaA MRK.DE
Merck KGaA (MRK.DE) earns a Piotroski F-score of 5/9 (mixed financial health), with an Altman Z″ in the safe zone. It pays a dividend yielding 0.44% (safety: safe). FY2025 revenue was $21.1B at a 12.4% net margin.
Price from month-end closes (Yahoo) — for reference, not real-time.
How it ranks in Healthcare · percentile among 23 companies
Percentile vs other Healthcare companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 5/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Altman Z″ components · safe zone
| Component | Value |
|---|---|
| Working capital / assets | 0.081 |
| Retained earnings / assets | 0.467 |
| EBIT / assets | 0.071 |
| Equity / liabilities | 1.25 |
FAQ
Is MRK.DE financially healthy?
Merck KGaA's Piotroski F-score is 5/9 (8–9 is excellent, 0–3 weak), and its Altman Z″ distress score is in the safe zone.
Does MRK.DE pay a dividend, and is it safe?
Yes. Merck KGaA pays a dividend yielding about 0.44% with a 10.9% payout ratio, rated “safe” for safety.
How profitable is MRK.DE?
In FY2025, Merck KGaA had a net margin of 12.4% and a return on equity of 9.1%.
Source: company filings via Yahoo Finance · DE · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.